WAF1/CIP1 structural abnormalities do not contribute to cell cycle deregulation in ovarian cancer
1996

WAF1/CIP1 Gene and Ovarian Cancer

Sample size: 36 publication Evidence: moderate

Author Information

Author(s): M Wan, KF Cofer, L Dubeau

Primary Institution: Kenneth Norris Jr. Comprehensive Cancer Center

Hypothesis

Mutations in the WAF1/CIP1 gene may contribute to the development of ovarian tumors lacking p53 mutations.

Conclusion

WAF1/CIP1 mutations are rare in ovarian carcinomas, suggesting they do not play a significant role in ovarian tumorigenesis.

Supporting Evidence

  • WAF1/CIP1 mutations were not found in any of the 36 ovarian carcinomas studied.
  • 12 out of 36 tumors showed a single nucleotide substitution at codon 31, but this was not considered a mutation.
  • There was no correlation between the polymorphism in the WAF1/CIP1 gene and p53 mutations or loss of heterozygosity.

Takeaway

The study looked at a gene called WAF1/CIP1 in ovarian cancer and found that it doesn't usually have mutations, which means it likely isn't a big cause of this type of cancer.

Methodology

The entire coding region of the WAF1/CIP1 gene was sequenced in 36 ovarian carcinomas, and loss of heterozygosity and p53 mutation analyses were performed.

Limitations

The study only examined a specific gene and did not explore other potential mechanisms of tumorigenesis.

Participant Demographics

Tumors were of ovarian epithelial origin, and DNA from normal individuals was obtained from volunteers of mixed ethnic origins, predominantly Hispanic.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication